Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection.

Lee H, Kim J, Kang YA, Kim DR, Sim B, Zelmer A, Fletcher HA, Dockrell HM, Smith SG, Cho SN.

Front Immunol. 2019 Apr 26;10:896. doi: 10.3389/fimmu.2019.00896. eCollection 2019.

2.

JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression.

Liu J, Wang T, Creighton CJ, Wu SP, Ray M, Janardhan KS, Willson CJ, Cho SN, Castro PD, Ittmann MM, Li JL, Davis RJ, DeMayo FJ.

Nat Commun. 2019 May 14;10(1):2148. doi: 10.1038/s41467-019-09843-1.

3.

A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.

Hur YG, Hong JY, Choi DH, Kim A, Park SY, Kwon M, Kang K, Lee JM, Dockrell HM, Lee Y, Joo H, Cho SN.

Yonsei Med J. 2019 Apr;60(4):375-380. doi: 10.3349/ymj.2019.60.4.375.

4.

Characterisation of genes differentially expressed in macrophages by virulent and attenuated Mycobacterium tuberculosis through RNA-Seq analysis.

Lee J, Lee SG, Kim KK, Lim YJ, Choi JA, Cho SN, Park C, Song CH.

Sci Rep. 2019 Mar 11;9(1):4027. doi: 10.1038/s41598-019-40814-0.

5.

Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain.

Kim WS, Kim H, Kwon KW, Cho SN, Shin SJ.

Front Microbiol. 2019 Feb 12;10:220. doi: 10.3389/fmicb.2019.00220. eCollection 2019.

6.

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

Lee M, Mok J, Kim DK, Shim TS, Koh WJ, Jeon D, Lee T, Lee SH, Kim JS, Park JS, Lee JY, Kim SY, Lee JH, Jo KW, Jhun BW, Kang YA, Ahn JH, Kim CK, Shin S, Song T, Shin SJ, Kim YR, Ahn H, Hahn S, Won HJ, Jang JY, Cho SN, Yim JJ.

Trials. 2019 Jan 16;20(1):57. doi: 10.1186/s13063-018-3053-1.

7.

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.

Kim SH, Roszik J, Cho SN, Ogata D, Milton DR, Peng W, Menter DG, Ekmekcioglu S, Grimm EA.

Clin Cancer Res. 2019 Mar 1;25(5):1650-1663. doi: 10.1158/1078-0432.CCR-18-1163. Epub 2018 Dec 11.

PMID:
30538110
8.

Phagocytosis influences the intracellular survival of Mycobacterium smegmatis via the endoplasmic reticulum stress response.

Kim SH, Cho SN, Lim YJ, Choi JA, Lee J, Go D, Song CH.

Cell Biosci. 2018 Sep 29;8:52. doi: 10.1186/s13578-018-0250-2. eCollection 2018.

9.

Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis.

Kim SY, Kim J, Kim DR, Kang YA, Bong S, Lee J, Kim S, Lee NS, Sim B, Cho SN, Kim YS, Lee H.

BMC Infect Dis. 2018 May 29;18(1):240. doi: 10.1186/s12879-018-3144-3.

10.

Validation and comparison of ELISA kits to measure interferon gamma responses in QuantiFERON cultural supernatants for diagnosis of tuberculosis.

Kim J, Bong S, Kim DR, Cho SN, Lee H.

J Microbiol Methods. 2018 Jul;150:29-31. doi: 10.1016/j.mimet.2018.05.007. Epub 2018 May 26.

PMID:
29758245
11.

IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

You R, DeMayo FJ, Liu J, Cho SN, Burt BM, Creighton CJ, Casal RF, Lazarus DR, Lu W, Tung HY, Yuan X, Hill-McAlester A, Kim M, Perusich S, Cornwell L, Rosen D, Song LZ, Paust S, Diehl G, Corry D, Kheradmand F.

Cancer Immunol Res. 2018 Jun;6(6):645-657. doi: 10.1158/2326-6066.CIR-17-0554. Epub 2018 Apr 13.

12.

TNF-α-mediated ER stress causes elimination of Mycobacterium fortuitum reservoirs by macrophage apoptosis.

Oh SM, Lim YJ, Choi JA, Lee J, Cho SN, Go D, Kim SH, Song CH.

FASEB J. 2018 Jul;32(7):3993-4003. doi: 10.1096/fj.201701407R. Epub 2018 Feb 26.

PMID:
29481309
13.

Enhancement of the antimycobacterial activity of macrophages by ajoene.

Choi JA, Cho SN, Lim YJ, Lee J, Go D, Kim SH, Song CH.

Innate Immun. 2018 Jan;24(1):79-88. doi: 10.1177/1753425917747975. Epub 2017 Dec 14.

PMID:
29239661
14.

Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.

Liu J, Cho SN, Wu SP, Jin N, Moghaddam SJ, Gilbert JL, Wistuba I, DeMayo FJ.

Lung Cancer. 2017 Oct;112:47-56. doi: 10.1016/j.lungcan.2017.08.001. Epub 2017 Aug 5.

15.

Calreticulin modulates the intracellular survival of mycobacteria by regulating ER-stress-mediated apoptosis.

Jo SH, Choi JA, Lim YJ, Lee J, Cho SN, Oh SM, Go D, Kim SH, Song CH.

Oncotarget. 2017 Apr 25;8(35):58686-58698. doi: 10.18632/oncotarget.17419. eCollection 2017 Aug 29.

16.

Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.

Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, Yuan X, Mo X, Zhu H, Xu P, Gao Q, Lee M, Lee J, Smith LE, Chen RY, Joh JS, Cho Y, Liu X, Ruan X, Liang L, Dharan N, Cho SN, Barry CE 3rd, Ellner JJ, Dorman SE, Alland D.

N Engl J Med. 2017 Sep 14;377(11):1043-1054. doi: 10.1056/NEJMoa1614915.

17.

Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.

Kim A, Hur YG, Gu S, Cho SN.

Clin Vaccine Immunol. 2017 Nov 6;24(11). pii: e00219-17. doi: 10.1128/CVI.00219-17. Print 2017 Nov.

18.

How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis?

Lee JH, Han CD, Cho SN, Yang IH, Lee WS, Baek SH, Shin JW, Husein KEI, Park KK.

Clin Orthop Relat Res. 2017 Nov;475(11):2795-2804. doi: 10.1007/s11999-017-5470-y. Epub 2017 Aug 9.

19.

Unique Chemokine Profiles of Lung Tissues Distinguish Post-chemotherapeutic Persistent and Chronic Tuberculosis in a Mouse Model.

Park S, Baek SH, Cho SN, Jang YS, Kim A, Choi IH.

Front Cell Infect Microbiol. 2017 Jul 13;7:314. doi: 10.3389/fcimb.2017.00314. eCollection 2017.

20.

Centrifugal Lithography: Self-Shaping of Polymer Microstructures Encapsulating Biopharmaceutics by Centrifuging Polymer Drops.

Yang H, Kim S, Kang G, Lahiji SF, Jang M, Kim YM, Kim JM, Cho SN, Jung H.

Adv Healthc Mater. 2017 Oct;6(19). doi: 10.1002/adhm.201700326. Epub 2017 Jul 13.

PMID:
28703882
21.

Investigation of bovine tuberculosis outbreaks by using a trace-back system and molecular typing in Korean Hanwoo beef cattle.

Ku BK, Jeon BY, Kim JM, Jang YB, Lee H, Choi JY, Jung SC, Nam HM, Park H, Cho SN.

J Vet Sci. 2018 Jan 31;19(1):45-50. doi: 10.4142/jvs.2018.19.1.45.

22.

Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.

Sharma A, Hill A, Kurbatova E, van der Walt M, Kvasnovsky C, Tupasi TE, Caoili JC, Gler MT, Volchenkov GV, Kazennyy BY, Demikhova OV, Bayona J, Contreras C, Yagui M, Leimane V, Cho SN, Kim HJ, Kliiman K, Akksilp S, Jou R, Ershova J, Dalton T, Cegielski P; Global Preserving Effective TB Treatment Study Investigators.

Lancet Infect Dis. 2017 Jul;17(7):707-715. doi: 10.1016/S1473-3099(17)30247-5. Epub 2017 May 9.

23.

Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.

Gröschel MI, Sayes F, Shin SJ, Frigui W, Pawlik A, Orgeur M, Canetti R, Honoré N, Simeone R, van der Werf TS, Bitter W, Cho SN, Majlessi L, Brosch R.

Cell Rep. 2017 Mar 14;18(11):2752-2765. doi: 10.1016/j.celrep.2017.02.057.

24.

Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K.

Kwon KW, Kim WS, Kim H, Han SJ, Hahn MY, Lee JS, Nam KT, Cho SN, Shin SJ.

Sci Rep. 2017 Mar 8;7:44151. doi: 10.1038/srep44151.

25.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.

Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16.

26.

Performance of the BacT Alert 3D System Versus Solid Media for Recovery and Drug Susceptibility Testing of Mycobacterium tuberculosis in a Tertiary Hospital in Korea.

Kim SC, Jeon BY, Kim JS, Choi IH, Kim J, Woo J, Kim S, Lee HW, Sezim M, Cho SN.

Tuberc Respir Dis (Seoul). 2016 Oct;79(4):282-288. Epub 2016 Oct 5.

27.

Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.

Kim GR, Cho SN, Kim HS, Yu SY, Choi SY, Ryu Y, Lin MQ, Jin L, Kee HJ, Jeong MH.

J Hypertens. 2016 Nov;34(11):2206-19. doi: 10.1097/HJH.0000000000001081.

PMID:
27512969
28.

An in vitro model of granuloma-like cell aggregates substantiates early host immune responses against Mycobacterium massiliense infection.

Je S, Quan H, Na Y, Cho SN, Kim BJ, Seok SH.

Biol Open. 2016 Aug 15;5(8):1118-27. doi: 10.1242/bio.019315.

29.

Seroprevalence of tuberculosis in domesticated elk (Cervus canadensis) in Korea.

Kang SS, Byeon HS, Ku BK, Kim SW, Kim J, Woo J, Ahn B, Kim S, Monoldorova S, Park CH, Cho SN, Jeon BY.

Res Vet Sci. 2016 Aug;107:228-232. doi: 10.1016/j.rvsc.2016.06.013. Epub 2016 Jun 20.

PMID:
27474000
30.

Krüppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.

Kim SH, Park YY, Cho SN, Margalit O, Wang D, DuBois RN.

PLoS One. 2016 Jul 21;11(7):e0159899. doi: 10.1371/journal.pone.0159899. eCollection 2016.

31.

The impact of social conditions on patient adherence to pulmonary tuberculosis treatment.

Choi H, Chung H, Muntaner C, Lee M, Kim Y, Barry CE, Cho SN.

Int J Tuberc Lung Dis. 2016 Jul;20(7):948-54. doi: 10.5588/ijtld.15.0759.

32.

Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis.

Hur YG, Chung WY, Kim A, Kim YS, Kim HS, Jang SH, Kim Y, Lee H, Park KJ, Cho SN.

J Infect. 2016 Jul;73(1):54-62. doi: 10.1016/j.jinf.2016.04.032. Epub 2016 May 4.

PMID:
27155519
33.

Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis.

Lingaraju S, Rigouts L, Gupta A, Lee J, Umubyeyi AN, Davidow AL, German S, Cho E, Lee JI, Cho SN, Kim CT, Alland D, Safi H.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4101-5. doi: 10.1128/AAC.03002-15. Print 2016 Jul.

34.

Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.

Kim WS, Kim JS, Cha SB, Kim H, Kwon KW, Kim SJ, Han SJ, Choi SY, Cho SN, Park JH, Shin SJ.

Oncotarget. 2016 May 3;7(18):24962-82. doi: 10.18632/oncotarget.8771.

35.

Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.

Cha SB, Kim WS, Kim JS, Kim H, Kwon KW, Han SJ, Cho SN, Coler RN, Reed SG, Shin SJ.

Vaccine. 2016 Apr 27;34(19):2179-87. doi: 10.1016/j.vaccine.2016.03.029. Epub 2016 Mar 20.

PMID:
27005808
36.

Safety and efficacy of tuberculin skin testing with microneedle MicronJet600™ in healthy adults.

Lee HJ, Choi HJ, Kim DR, Lee H, Jin JE, Kim YR, Lee MS, Cho SN, Kang YA.

Int J Tuberc Lung Dis. 2016 Apr;20(4):500-4. doi: 10.5588/ijtld.15.0678.

PMID:
26970160
37.

A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus.

Kim JS, Cha SH, Kim WS, Han SJ, Cha SB, Kim HM, Kwon KW, Kim SJ, Choi HH, Lee J, Cho SN, Koh WJ, Park YM, Shin SJ.

Stem Cells. 2016 Jul;34(7):1957-70. doi: 10.1002/stem.2353. Epub 2016 Mar 27.

38.

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.

Song T, Lee M, Jeon HS, Park Y, Dodd LE, Dartois V, Follman D, Wang J, Cai Y, Goldfeder LC, Olivier KN, Xie Y, Via LE, Cho SN, Barry CE 3rd, Chen RY.

EBioMedicine. 2015 Oct 9;2(11):1627-33. doi: 10.1016/j.ebiom.2015.09.051. eCollection 2015 Nov.

39.

Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.

Kim SH, Hashimoto Y, Cho SN, Roszik J, Milton DR, Dal F, Kim SF, Menter DG, Yang P, Ekmekcioglu S, Grimm EA.

Pigment Cell Melanoma Res. 2016 May;29(3):297-308. doi: 10.1111/pcmr.12455. Epub 2016 Mar 15.

40.

Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.

Lee SJ, Desta KT, Eum SY, Dartois V, Cho SN, Bae DW, Shin SC.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 15;1009-1010:138-43. doi: 10.1016/j.jchromb.2015.11.058. Epub 2015 Dec 8.

PMID:
26730550
41.

Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis.

Kim WS, Kim JS, Cha SB, Han SJ, Kim H, Kwon KW, Kim SJ, Eum SY, Cho SN, Shin SJ.

PLoS One. 2015 Dec 16;10(12):e0145234. doi: 10.1371/journal.pone.0145234. eCollection 2015.

42.

Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.

Cha SB, Kim WS, Kim JS, Kim H, Kwon KW, Han SJ, Eum SY, Cho SN, Shin SJ.

PLoS One. 2015 Oct 28;10(10):e0141577. doi: 10.1371/journal.pone.0141577. eCollection 2015.

43.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Cegielski JP, Kurbatova E, van der Walt M, Brand J, Ershova J, Tupasi T, Caoili JC, Dalton T, Contreras C, Yagui M, Bayona J, Kvasnovsky C, Leimane V, Kuksa L, Chen MP, Via LE, Hwang SH, Wolfgang M, Volchenkov GV, Somova T, Smith SE, Akksilp S, Wattanaamornkiet W, Kim HJ, Kim CK, Kazennyy BY, Khorosheva T, Kliiman K, Viiklepp P, Jou R, Huang AS, Vasilyeva IA, Demikhova OV; Global PETTS Investigators, Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG.

Clin Infect Dis. 2016 Feb 15;62(4):418-430. doi: 10.1093/cid/civ910. Epub 2015 Oct 27.

44.

Mycobacterium tuberculosis MmsA, a novel immunostimulatory antigen, induces dendritic cell activation and promotes Th1 cell-type immune responses.

Kim JS, Kim WS, Choi HH, Kim HM, Kwon KW, Han SJ, Cha SB, Cho SN, Koh WJ, Shin SJ.

Cell Immunol. 2015 Nov-Dec;298(1-2):115-25. doi: 10.1016/j.cellimm.2015.10.005. Epub 2015 Oct 23.

PMID:
26507911
45.

Complete genome sequence of Mycobacterium tuberculosis K from a Korean high school outbreak, belonging to the Beijing family.

Han SJ, Song T, Cho YJ, Kim JS, Choi SY, Bang HE, Chun J, Bai GH, Cho SN, Shin SJ.

Stand Genomic Sci. 2015 Oct 14;10:78. doi: 10.1186/s40793-015-0071-4. eCollection 2015.

46.

Performance of PCR-reverse blot hybridization assay for detection of rifampicin-resistant Mycobacterium leprae.

Wang HY, Kim H, Kim Y, Bang H, Kim JP, Hwang JH, Cho SN, Kim TU, Lee H.

J Microbiol. 2015 Oct;53(10):686-93. doi: 10.1007/s12275-015-5057-9. Epub 2015 Oct 2.

PMID:
26428919
47.

Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model.

Cha SB, Jeon BY, Kim WS, Kim JS, Kim HM, Kwon KW, Cho SN, Shin SJ, Koh WJ.

PLoS One. 2015 Sep 25;10(9):e0139251. doi: 10.1371/journal.pone.0139251. eCollection 2015.

48.

The association between sterilizing activity and drug distribution into tuberculosis lesions.

Prideaux B, Via LE, Zimmerman MD, Eum S, Sarathy J, O'Brien P, Chen C, Kaya F, Weiner DM, Chen PY, Song T, Lee M, Shim TS, Cho JS, Kim W, Cho SN, Olivier KN, Barry CE 3rd, Dartois V.

Nat Med. 2015 Oct;21(10):1223-7. doi: 10.1038/nm.3937. Epub 2015 Sep 7.

49.

Conventional and real-time PCR targeting 16S ribosomal RNA for the detection of Mycobacterium tuberculosis complex.

Choi Y, Hong SR, Jeon BY, Wang HY, Lee GS, Cho SN, Shim TS, Lee H.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1102-8, i-ii. doi: 10.5588/ijtld.14.0472.

PMID:
26260833
50.

Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar.

Aung WW, Ei PW, Nyunt WW, Swe TL, Lwin T, Htwe MM, Kim KJ, Lee JS, Kim CK, Cho SN, Song SD, Chang CL.

Ann Lab Med. 2015 Sep;35(5):494-9. doi: 10.3343/alm.2015.35.5.494.

Supplemental Content

Support Center